| __timestamp | Ionis Pharmaceuticals, Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 7459000 |
| Thursday, January 1, 2015 | 322292000 | 11831000 |
| Friday, January 1, 2016 | 344320000 | 25705000 |
| Sunday, January 1, 2017 | 374644000 | 46181000 |
| Monday, January 1, 2018 | 414604000 | 59497000 |
| Tuesday, January 1, 2019 | 466000000 | 65003000 |
| Wednesday, January 1, 2020 | 535000000 | 74506000 |
| Friday, January 1, 2021 | 643000000 | 126006000 |
| Saturday, January 1, 2022 | 833000000 | 126215000 |
| Sunday, January 1, 2023 | 899625000 | 120161000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc. have demonstrated contrasting R&D investment strategies. From 2014 to 2023, Ionis Pharmaceuticals increased its R&D spending by nearly 272%, peaking at approximately $900 million in 2023. This robust growth underscores Ionis's aggressive pursuit of new therapies and technologies. In contrast, Protagonist Therapeutics, while showing a steady increase, expanded its R&D budget by about 1,500% over the same period, reaching around $120 million in 2023. This significant growth, albeit from a smaller base, highlights Protagonist's strategic scaling in the biotech arena. These trends reflect broader industry dynamics, where strategic R&D investments are pivotal for long-term success and innovation.
Sanofi vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
United Therapeutics Corporation or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Protagonist Therapeutics, Inc. vs MiMedx Group, Inc.: Strategic Focus on R&D Spending